Search for: "Schering Corp"
Results 161 - 180
of 251
Sorted by Relevance
|
Sort by Date
10 Jun 2014, 7:50 pm
” Schering Corp. v. [read post]
5 Mar 2013, 12:36 pm
737 F.Supp.2d at 922-23 (citing In re Schering–Plough Corp. [read post]
3 Sep 2015, 6:36 am
Stryker Corp., 788 F. [read post]
7 Jul 2010, 11:10 am
In re Novartis Wage and Hour Litigation This case was before the Second Circuit on Plaintiffs’ appeal of the lower Court’s Order granting Defendant summary judgment, which held that Plaintiffs, Pharmaceutical Representatives, were exempt from the overtime provisions of the FLSA under both the outside sales exemption and the administrative sales exemption. [read post]
31 Jul 2023, 1:47 pm
Schering Corp. v. [read post]
26 Aug 2009, 5:14 pm
"); Bayer Schering Pharma AG v. [read post]
24 Apr 2007, 4:18 pm
.; Schering Corp. v. [read post]
30 Jul 2009, 7:02 am
The same Bloomberg article also re-caps the most recent (albeit a bit dated) information about the extent of this ongoing Fosamax litigation: Merck, which is buying rival Schering-Plough Corp., had a reserve of about $24 million for the litigation, including lawyers' fees, as of March 31, having spent $9 million on the cases in the first quarter, the company said in May. [read post]
31 Aug 2010, 10:01 pm
– state of research and development of new drugs in Indian pharma industry (Spicy IP) US: The Financial Times’ take on gene patenting (Patent Docs) US: Seattle Biotech companies fight over allegedly similar names: Mirina Corp. v. [read post]
10 Mar 2010, 5:22 am
(Patent Docs) (GenericsWeb) Protonix (Pantoprazole) - US: District Court dismisses Wyeth Lanham Act case concerning generic Protonix, but leaves the door open for further litigation (FDA Law Blog) ReFacto (Moroctocog alfa)- US: Novartis prevails over Pfizer in ReFacto suit (Patent Docs) Vytorin (Ezetimibe, Simvastatin) – US: Infringement of patent following a Paragraph IV certification: Schering Corp. et al. v. [read post]
24 Mar 2010, 4:45 am
(En Banc Decision) (Patently-O) (Patent Docs) (Holman's Biotech IP Blog) (Inventive Step) US: CAFC transfers ‘hot potato’ diagnostic method case: Laboratory Corp. of America Holdings v. [read post]
4 Aug 2009, 1:15 am
Merck, which is buying rival Schering-Plough Corp., had a reserve of about $24 million for the litigation, including lawyers' fees, as of March 31, having spent $9 million on the cases in the first quarter, the company said in May. [read post]
24 Apr 2007, 1:18 am
.; Schering Corp. v. [read post]
7 Apr 2011, 11:37 am
See Schering Corp. v. [read post]
26 Nov 2007, 3:06 pm
The October 2007 FDA staff report was prepared in advance of a meeting of an advisory panel of pediatricians later this week being convened to consider the safety of Serevent and Advair (made by GlaxoSmithKline PLC), both of which contain the active ingredient salmeterol, as well as another asthma drug, Foradil (made by Novartis AG and marketed in the U.S. by Schering-Plough Corp.), which contains the active ingredient formoterol. [read post]
1 Apr 2011, 12:42 pm
See Schering Corp. v. [read post]
10 Mar 2010, 5:22 am
(Patent Docs) (GenericsWeb) Protonix (Pantoprazole) - US: District Court dismisses Wyeth Lanham Act case concerning generic Protonix, but leaves the door open for further litigation (FDA Law Blog) ReFacto (Moroctocog alfa)- US: Novartis prevails over Pfizer in ReFacto suit (Patent Docs) Vytorin (Ezetimibe, Simvastatin) – US: Infringement of patent following a Paragraph IV certification: Schering Corp. et al. v. [read post]
29 Jun 2010, 6:01 pm
(Patent Docs) Zetia (Ezetimibe) – US: Patent infringement complaint filed following a Paragraph IV certification: Schering Corporation et al. v. [read post]
30 Jun 2010, 5:52 am
(Patent Docs) Zetia (Ezetimibe) – US: Patent infringement complaint filed following a Paragraph IV certification: Schering Corporation et al. v. [read post]
12 Mar 2010, 6:48 am
See In re Schering Plough Corp. [read post]
